Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication

Area of Science:

• Hepatology
• Gastroenterology
• Infectious Diseases

Background:

• A proposed link exists between Helicobacter pylori (H. pylori) infection and hepatic encephalopathy in cirrhosis patients.
• Existing data are insufficient to confirm a significant association between H. pylori and hepatic encephalopathy.
• Subclinical portosystemic encephalopathy and ammonia levels are key indicators in cirrhotic patients.

Purpose of the Study:

• To prospectively evaluate the influence of H. pylori status on ammonia levels and subclinical hepatic encephalopathy indicators in cirrhotic patients.
• To investigate the impact of H. pylori eradication therapy on these neurological and biochemical parameters.

Main Methods:

• Assessed 62 cirrhotic patients for H. pylori infection using rapid urease test and 14C-urea breath test.
• Measured fasting blood ammonia levels, mental state, number connection test, flapping tremor, and EEG tracings at baseline.
• Reassessed parameters in H. pylori-positive patients two months post-eradication therapy.

Main Results:

• Prevalence of H. pylori infection was 52% in non-advanced cirrhotic patients.
• No significant differences in ammonia levels or portosystemic encephalopathy indicators were found between H. pylori-positive and H. pylori-negative groups.
• H. pylori eradication did not significantly alter ammonia levels or neurologic disturbances.

Conclusions:

• H. pylori infection is not a primary factor contributing to elevated ammonia levels in non-advanced cirrhotic patients.
• H. pylori status does not significantly affect indicators of subclinical portosystemic encephalopathy in this patient group.
• Eradication of H. pylori does not improve ammonia levels or neurologic parameters associated with hepatic encephalopathy.